CANF
Can-Fite BioPharma
CANF
CANF
12 hedge funds and large institutions have $1.05M invested in Can-Fite BioPharma in 2021 Q2 according to their latest regulatory filings, with 2 funds opening new positions, 1 increasing their positions, 3 reducing their positions, and 5 closing their positions.
Holders
12
Holders Change
-3
Holders Change %
-20%
% of All Funds
0.21%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
2
Increased
1
Reduced
3
Closed
5
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
1
Morgan Stanley
New York
|
$421K |
| 2 |
SG
2
StoneX Group
New York
|
$91K |
| 3 |
3
UBS Group
Zurich,
Switzerland
|
$18K |
Top Sellers
| 1 |
VF
1
Virtu Financial
New York
|
$0 |
| 2 |
TSS
2
Two Sigma Securities
New York
|
$23K |
| 3 |
3
Citadel Advisors
Miami,
Florida
|
$88K |
| 4 |
XT
4
XTX Topco
George Town,
Cayman Islands
|
$0 |
| 5 |
5
Jane Street
New York
|
$0 |
